RLI Corp. (RLI) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 423.87M | 465.69M | 509.26M | 499.83M | 407.67M | 439.12M | 470M | 416.44M | 444.83M | 445.37M | 331.69M | 381.86M |
| Revenue Growth % | 3.98% | 6.05% | 8.36% | 20.02% | -8.36% | -1.4% | 41.7% | 9.06% | 21.9% | 21.53% | -61.41% | 79.2% |
| Medical Costs & Claims | 193.24M | 306.4M | 347.15M | 339.67M | 327.8M | 374.93M | 348.8M | 309.04M | 282.98M | 143.62M | 314.16M | 281.08M |
| Medical Cost Ratio % | 45.59% | 65.79% | 68.17% | 67.96% | 80.41% | 85.38% | 74.21% | 74.21% | 63.62% | 32.25% | 94.71% | 73.61% |
| Gross Profit | 230.63M | 159.29M | 162.11M | 160.15M | 79.87M | 64.18M | 121.2M | 107.4M | 161.85M | 301.75M | 17.53M | 100.78M |
| Gross Margin % | 54.41% | 34.21% | 31.83% | 32.04% | 19.59% | 14.62% | 25.79% | 25.79% | 36.38% | 67.75% | 5.29% | 26.39% |
| Gross Profit Growth % | 188.77% | 148.19% | 33.76% | 49.12% | -50.65% | -78.73% | 591.3% | 6.57% | 29.39% | 17.56% | -96.96% | 832.33% |
| Operating Expenses | 163.28M | 33.41M | 4.87M | 3.64M | 1.24M | 16.75M | 4.37M | 4.1M | 1.86M | 158.33M | 2.51M | 4.75M |
| OpEx / Revenue % | 38.52% | 7.17% | 0.96% | 0.73% | 0.3% | 3.81% | 0.93% | 0.98% | 0.42% | 35.55% | 0.76% | 1.24% |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | 84.11% | 72.97% | 69.12% | 68.69% | 80.71% | 89.2% | 75.14% | 75.19% | 64.03% | 67.8% | 95.47% | 74.85% |
| Operating Income | 67.34M | 125.88M | 157.25M | 156.51M | 78.63M | 47.43M | 116.83M | 103.3M | 159.99M | 143.42M | 15.02M | 96.03M |
| Operating Margin % | 15.89% | 27.03% | 30.88% | 31.31% | 19.29% | 10.8% | 24.86% | 24.81% | 35.97% | 32.2% | 4.53% | 25.15% |
| Operating Income Growth % | -14.36% | 165.39% | 34.6% | 51.51% | -50.85% | -66.93% | 677.85% | 7.57% | 30.3% | 25.8% | -97.29% | 1565.23% |
| EBITDA | 69.69M | 125.88M | 158.61M | 157.87M | 79.97M | 48.92M | 118.44M | 104.91M | 161.61M | 144.8M | 16.89M | 98.08M |
| EBITDA Margin % | 16.44% | 27.03% | 31.14% | 31.58% | 19.62% | 11.14% | 25.2% | 25.19% | 36.33% | 32.51% | 5.09% | 25.68% |
| Interest Expense | 2.35M | 1.31M | 1.36M | 1.35M | 1.33M | 1.49M | 1.62M | 1.6M | 1.62M | 1.37M | 1.87M | 2.05M |
| Non-Operating Income | -2.35M | 0 | -1.36M | -1.35M | -1.33M | -1.49M | -1.62M | -1.6M | -1.62M | -1.37M | -1.87M | -2.05M |
| Pretax Income | 67.34M | 113.59M | 157.25M | 156.51M | 78.63M | 47.43M | 116.83M | 103.3M | 159.99M | 143.42M | 15.02M | 96.03M |
| Pretax Margin % | 15.89% | 24.39% | 30.88% | 31.31% | 19.29% | 10.8% | 24.86% | 24.81% | 35.97% | 32.2% | 4.53% | 25.15% |
| Income Tax | 12.46M | 22.41M | 32.63M | 32.18M | 15.42M | 6.57M | 21.8M | 21.31M | 32.09M | 28.81M | 1.48M | 18.38M |
| Effective Tax Rate % | 18.5% | 19.73% | 20.75% | 20.56% | 19.61% | 13.86% | 18.66% | 20.63% | 20.06% | 20.09% | 9.87% | 19.14% |
| Net Income | 54.88M | 91.18M | 124.61M | 124.34M | 63.21M | 40.86M | 95.03M | 81.99M | 127.9M | 114.61M | 13.54M | 77.65M |
| Net Margin % | 12.95% | 19.58% | 24.47% | 24.88% | 15.51% | 9.31% | 20.22% | 19.69% | 28.75% | 25.73% | 4.08% | 20.34% |
| Net Income Growth % | -13.18% | 123.14% | 31.13% | 51.64% | -50.58% | -64.35% | 602.03% | 5.59% | 29.44% | 17.15% | -96.92% | 3568.16% |
| EPS (Diluted) | 0.60 | 0.99 | 1.35 | 1.34 | 0.68 | 0.44 | 1.03 | 0.89 | 1.39 | 1.25 | 0.15 | 0.85 |
| EPS Growth % | -11.76% | 125% | 31.07% | 50.56% | -51.08% | -64.8% | 586.67% | 5.33% | 29.3% | 17.37% | -96.88% | 3521.05% |
| EPS (Basic) | 0.60 | 0.99 | 1.35 | 1.35 | 0.69 | 0.45 | 1.03 | 0.90 | 1.40 | 1.25 | 0.15 | 0.85 |
| Diluted Shares Outstanding | 92.19M | 92.22M | 92.31M | 92.52M | 92.53M | 92.45M | 92.44M | 92.36M | 92.33M | 92.14M | 92.13M | 92.09M |